Side-by-side comparison of AI visibility scores, market position, and capabilities
NYSE-listed global HIIT fitness franchise (FXLV) with 1,750+ locations in 63 countries; team-based 45-minute workouts with daily programmed content competing with Orangetheory for boutique fitness.
F45 Training is a global fitness franchise offering 45-minute team-based high-intensity interval training (HIIT) workouts that combine functional movement patterns with circuit-style training — rotating through hundreds of different workout formats to prevent adaptation and keep members motivated. Listed on NYSE (NYSE: FXLV) following its 2021 IPO at a peak market cap exceeding $1 billion, F45 was founded in 2013 in Sydney, Australia by Rob Deutsch and Luke Istomin, grew to 1,750+ locations in 63+ countries, and received $200 million in investment from actor Mark Wahlberg.
Rare disease biotech developing polytherapy approach for Rett Syndrome (1 in 10,000 girls); founder-developed protocol validated through personal patient experience competing with Acadia Pharmaceuticals Daybue in Rett market.
Uncommon Therapeutics is a biotech company founded by Noah Auerhahn — directly inspired by his daughter's diagnosis with Rett Syndrome, a severe genetic neurological disease affecting approximately 1 in 10,000 girls — applying a polytherapy approach (combining multiple therapeutic agents targeting different disease mechanisms simultaneously) to develop treatments for serious neurological and rare diseases. After improving his daughter's quality of life through a personally developed polytherapy protocol, Auerhahn founded Uncommon Therapeutics to translate these insights into pharmaceutical products for the broader Rett Syndrome patient community.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.